دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 4,800,000 تومان- قیمت ویژه : 2,400,000تومان
پکیج دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
- :
قیمت : 1,500,000 تومان- قیمت ویژه : 750,000تومان
پکیج دسترسی یکماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 31 ﺭﻭﺯ
قیمت : 600,000 تومان- قیمت ویژه : 300,000تومان
Establishing a Role for Local Therapy in Oligometastatic Pancreatic Cancer
doi : 10.1200/JCO-24-01264
2024, Volume 42 (32)
Stockholm3 in a Multiethnic Cohort: Optimizing Prostate Cancer Screening to Reduce Harm and Improve Equity
doi : 10.1200/JCO.24.00941
Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration–Approved Anticancer Drugs: A Call for Systematic Data Availability
doi : 10.1200/JCO.24.00539
Oncology Accelerated Approval Confirmatory Trials: When a Failed Trial Is Not a Failed Drug
doi : 10.1200/JCO-24-01654
Equipoise Lost? Trial Conduct Challenges in an Era of Breakthrough Therapies
doi : 10.1200/JCO-24-01200
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)
doi : 10.1200/JCO.24.00554
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial
doi : 10.1200/JCO.24.00081
Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial
doi : 10.1200/JCO.24.00152
Trastuzumab Deruxtecan in Advanced Solid Tumors With Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial
doi : 10.1200/JCO.23.02626
Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer: Results of the Prevalence Round
doi : 10.1200/JCO.22.02819
Breast Cancer Screening Interval: Effect on Rate of Late-Stage Disease at Diagnosis and Overall Survival
doi : 10.1200/JCO.24.00285
Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors
doi : 10.1200/JCO.24.00186
Structural Racism and Treatment Delay Among Black and White Patients With Breast Cancer
doi : 10.1200/JCO.23.02483
Racial Differences in Breast Cancer Survival Between Black and White Women According to Tumor Subtype: A Systematic Review and Meta-Analysis
doi : 10.1200/JCO.23.02311
How Could We Further Improve the Gilteritinib Maintenance After Allogeneic Hematopoietic Cell Transplantation in FLT3 -Mutated AML?
doi : 10.1200/JCO.24.00566
Neoadjuvant Sonic Hedgehog Inhibitors Combined With Radiotherapy Is a Promising Strategy for Locally Advanced Basal Cell Carcinoma
doi : 10.1200/JCO.24.01042
Erratum: Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine–DNA Methyltransferase Biomarker Analyses
doi : 10.1200/JCO-24-02040
